Algeta to Participate in Upcoming Investor Conferences  
2/20/2013 9:17:22 AM

OSLO, NORWAY--(Marketwire - February 20, 2013) - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its senior management team will participate in the following upcoming investor conferences:

Citi Global Healthcare Conference 2013

Date: 25-27 February 2013


Jeff Albers (President, Algeta US)

Mike Booth (IR)

Panel date & time: Tuesday 25 February, 2013, 10:20am EST

Venue: New York, NY, USA

Credit Suisse Global Healthcare One-on-One Conference

Date: 5-6 March 2013


Andrew Kay (President & CEO)

Oystein Soug (CFO)

Mike Booth (IR)

Venue: London, UK

Carnegie Nordic Healthcare Seminar

Date: 12 March 2013


Thomas Ramdahl (EVP & CTO)

Renate Birkeli (IR)

Presentation date & time: Tuesday 12 March, 2013, 10:05am CET

Venue: Stockholm, Sweden

Presentations, where applicable, will be available to download at following these events.


About Algeta

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit

Press release:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE


For further information, please contact:

Mike Booth / Renate Birkeli
+47 23 00 67 32
Communications & Corporate Affairs
Email Contact

Media enquiries:
Mark Swallow
+44 207 638 9571

Citigate Dewe Rogerson
Email Contact

Knut Ekern
+47 22 04 82 00

Gambit Hill & Knowlton
Email Contact

Kari Watson
+1 781 235 3060

MacDougall Biomedical Communications
Email Contact

US investor enquiries:
Tricia Swanson
+1 646 378 2953

The Trout Group
Email Contact